OFIX Quote, Financials, Valuation and Earnings

InfuSystems Holdings has a net margin of -13.93% compared to Orthofix Medical's net margin of 5.12%. Orthofix Medical's return on equity of -20.83% beat InfuSystems Holdings's return on equity of 2.8%.

Orthofix Medical has a consensus price target of --, signalling upside risk potential of 40.8%. On the other hand InfuSystems Holdings has an analysts' consensus of -- which suggests that it could grow by 73.31%. Given that InfuSystems Holdings has higher upside potential than Orthofix Medical, analysts believe InfuSystems Holdings is more attractive than Orthofix Medical.

Orthofix Medical has a beta of 1.087, which suggesting that the stock is 8.701% more volatile than S&P 500. In comparison InfuSystems Holdings has a beta of 1.528, suggesting its more volatile than the S&P 500 by 52.819%.

Orthofix Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InfuSystems Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Orthofix Medical pays -- of its earnings as a dividend. InfuSystems Holdings pays out -- of its earnings as a dividend.

Orthofix Medical quarterly revenues are $196.6M, which are larger than InfuSystems Holdings quarterly revenues of $35.3M. Orthofix Medical's net income of -$27.4M is lower than InfuSystems Holdings's net income of $1.8M. Notably, Orthofix Medical's price-to-earnings ratio is -- while InfuSystems Holdings's PE ratio is 128.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Orthofix Medical is 0.84x versus 1.32x for InfuSystems Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Retractable Technologies has a net margin of -13.93% compared to Orthofix Medical's net margin of -18.58%. Orthofix Medical's return on equity of -20.83% beat Retractable Technologies's return on equity of -16.83%.

Orthofix Medical has a consensus price target of --, signalling upside risk potential of 40.8%. On the other hand Retractable Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that Orthofix Medical has higher upside potential than Retractable Technologies, analysts believe Orthofix Medical is more attractive than Retractable Technologies.

Orthofix Medical has a beta of 1.087, which suggesting that the stock is 8.701% more volatile than S&P 500. In comparison Retractable Technologies has a beta of 1.979, suggesting its more volatile than the S&P 500 by 97.877%.

Orthofix Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Retractable Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Orthofix Medical pays -- of its earnings as a dividend. Retractable Technologies pays out -3.32% of its earnings as a dividend.

Orthofix Medical quarterly revenues are $196.6M, which are larger than Retractable Technologies quarterly revenues of $10.3M. Orthofix Medical's net income of -$27.4M is lower than Retractable Technologies's net income of -$1.9M. Notably, Orthofix Medical's price-to-earnings ratio is -- while Retractable Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Orthofix Medical is 0.84x versus 0.49x for Retractable Technologies. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision has a net margin of -13.93% compared to Orthofix Medical's net margin of -4291.67%. Orthofix Medical's return on equity of -20.83% beat Catheter Precision's return on equity of -65.84%.

Orthofix Medical has a consensus price target of --, signalling upside risk potential of 40.8%. On the other hand Catheter Precision has an analysts' consensus of -- which suggests that it could grow by 476.37%. Given that Catheter Precision has higher upside potential than Orthofix Medical, analysts believe Catheter Precision is more attractive than Orthofix Medical.

Orthofix Medical has a beta of 1.087, which suggesting that the stock is 8.701% more volatile than S&P 500. In comparison Catheter Precision has a beta of -0.210, suggesting its less volatile than the S&P 500 by 121.025%.

Orthofix Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Orthofix Medical pays -- of its earnings as a dividend. Catheter Precision pays out -- of its earnings as a dividend.

Orthofix Medical quarterly revenues are $196.6M, which are larger than Catheter Precision quarterly revenues of $96K. Orthofix Medical's net income of -$27.4M is lower than Catheter Precision's net income of -$4.1M. Notably, Orthofix Medical's price-to-earnings ratio is -- while Catheter Precision's PE ratio is 0.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Orthofix Medical is 0.84x versus 0.93x for Catheter Precision. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings has a net margin of -13.93% compared to Orthofix Medical's net margin of -17.98%. Orthofix Medical's return on equity of -20.83% beat Xtant Medical Holdings's return on equity of -35.98%.

Orthofix Medical has a consensus price target of --, signalling upside risk potential of 40.8%. On the other hand Xtant Medical Holdings has an analysts' consensus of -- which suggests that it could grow by 458.31%. Given that Xtant Medical Holdings has higher upside potential than Orthofix Medical, analysts believe Xtant Medical Holdings is more attractive than Orthofix Medical.

Orthofix Medical has a beta of 1.087, which suggesting that the stock is 8.701% more volatile than S&P 500. In comparison Xtant Medical Holdings has a beta of 0.357, suggesting its less volatile than the S&P 500 by 64.342%.

Orthofix Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Orthofix Medical pays -- of its earnings as a dividend. Xtant Medical Holdings pays out -- of its earnings as a dividend.

Orthofix Medical quarterly revenues are $196.6M, which are larger than Xtant Medical Holdings quarterly revenues of $27.9M. Orthofix Medical's net income of -$27.4M is lower than Xtant Medical Holdings's net income of -$5M. Notably, Orthofix Medical's price-to-earnings ratio is -- while Xtant Medical Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Orthofix Medical is 0.84x versus 0.47x for Xtant Medical Holdings. Usually stocks with elevated PS ratios are considered overvalued.